NKGN - NKGen Biotech Price Chart

NKGen Biotech, Inc. (NKGN) faces stringent FDA oversight and patent pressure within the cell therapy sector, while the 0.19 metric characterizes current dynamics. The stock's price history clearly demonstrates market expectations as the company utilizes modern sterile facilities equipped with updated cryogenic hardware. The development of methods to combat oncology and dementia allows the biotech firm to effectively expand its presence in high-tech medicine.

NKGN - NKGen Biotech, Inc. Price Rate Chart over the range 02/21/2024 - 03/15/2025

NKGen (NKGN) - metric breakdowns and financial figures

- stock value and consensus price forecast:

Price Chart NKGen|NKGN - Broker Consensus Forecast

- market capitalization statistics:

Market Value NKGen|NKGN - Enterprise Value

- balance sheet equity data:

Book Value per Share NKGen Biotech|NKGN - Book Value of Business|Market Value to Book Value Ratio nkgenbiotech.com|NKGN - Total Business Assets

- company liabilities and liquidity data:

- earnings and market ratios statistics:

NKGN - Company Net Income|Expected Profit NKGen Biotech, Inc.|NKGN - Price to Earnings Multiple|Future Price to Earnings NKGen Biotech Inc|NKGN - PEG Multiple|EV/EBITDA Multiple NKGen Biotech Corp|NKGN - Operating profit before depreciation charges|Net earnings per share (EPS TTM) NKGen Biotech|NKGN - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months nkgenbiotech.com|NKGN - Earnings per share growth this year|Expected earnings per share growth for next year NKGen Biotech, Inc.

- revenue and sales details:

NKGN - Company Sales Revenue|Projected Sales Volume NKGen Biotech|NKGN - Price-to-Revenue Ratio|Forward P/S Multiple NKGen Biotech, Inc.

Analysis of all company metrics:nkgenbiotech.com NKGN

The price reflects the current market consensus on the valuation of NKGen Biotech, Inc. (NKGN), where expectations for the success of its Alzheimer's disease therapy clash with the risks of cash burn. Analyzing the price action history, an investor can identify the equilibrium point of supply and demand, which, amid sideways consolidation, signals uncertainty before exiting the accumulation phase toward a new trend.

Analysis of competing companies